Yield10 Bioscience Revenue and Competitors

Boston, MA USA

Location

$121.7M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Yield10 Bioscience's estimated annual revenue is currently $7.6M per year.(i)
  • Yield10 Bioscience's estimated revenue per employee is $161,596
  • Yield10 Bioscience's total funding is $121.7M.

Employee Data

  • Yield10 Bioscience has 47 Employees.(i)
  • Yield10 Bioscience grew their employee count by 4% last year.

Yield10 Bioscience's People

NameTitleEmail/Phone
1
Chief Science Officer and VP ResearchReveal Email/Phone
2
VP, Finance, and Chief Accounting OfficerReveal Email/Phone
3
ControllerReveal Email/Phone
4
VP, Planning and Corporate CommunicationsReveal Email/Phone
5
Head Analytical ChemistryReveal Email/Phone
6
Director Regulatory AffairsReveal Email/Phone
7
Senior Director, Seed OperationsReveal Email/Phone
8
Senior Manager - Field Trials and AgronomyReveal Email/Phone
9
President and CEOReveal Email/Phone
10
Research Associate/Regulatory Affairs specialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Yield10 Bioscience?

Yield10 Bioscience is an agricultural bioscience company focusing on the development of disruptive technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. Experts forecast that food production must be increased by over 70% in the next 35 years to feed the growing global population, which is expected to increase from 7 billion to more than 9.6 billion by 2050. Yield10 is focused on new agricultural biotechnology approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is working to develop, validate and commercialize new traits and identify gene editing targets in several key crops including canola, soybean and corn. Yield10 was launched by Metabolix, Inc. in 2015 and is traded on Nasdaq (YTEN). Yield10 is headquartered in Woburn, MA and has an additional agricultural science facility with greenhouses in Saskatoon, Saskatchewan, Canada.

keywords:N/A

$121.7M

Total Funding

47

Number of Employees

$7.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Yield10 Bioscience News

2022-04-17 - Yield10 Bioscience Names Willie Loh, Ph.D., Former Cargill Executive, as Special Commercial and Technical Advisor

(Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today named Willie Loh, Ph.D., as a special advisor to the Board...

2022-04-13 - Yield10 Bioscience (NASDAQ:YTEN) Coverage Initiated by ...

Yield10 Bioscience, Inc, an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in...

2022-04-06 - Will Yield10 Bioscience Inc (YTEN) Stay at the Bottom of the Basic Materials Sector?

Additionally, Yield10 Bioscience Inc scored a 22 in the Basic Materials sector, ranking it higher than 22% of stocks in that sector.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.2M47-35%N/A
#2
$6.8M477%N/A
#3
$6M47-4%N/A
#4
$5.6M48N/AN/A
#5
$9.2M482%N/A